BioGaia Press releases

Latest press releases and news

View all press releases and news

BioGaia AB extends long-standing distribution partnership with Ewopharma

BioGaia AB (NASDAQ: BIOG) has signed a renewed distribution agreement with Ewopharma. The extended agreement reinforces the companies’ successful collaboration to date and reflects a shared ambition to further accelerate growth across the European region. Ewopharma is a pharmaceutical marketing organization and commercialization partner active in Central Eastern Europe and Switzerland, with expertise spanning prescription […]
Regulatory

BioGaia AB: Year-end report January – December 2025

FOURTH QUARTER 2025 (Figures in parentheses refer to the corresponding period last year, unless otherwise specified.) Net sales amounted to SEK 440.6 million (364.8), an increase of SEK 75.7 million, an organic sales increase of 32% (21% including foreign exchange effects). Net sales in the Pediatrics segment amounted to SEK 331.5 million (270.3), an organic […]
Regulatory

BioGaia’s results for the fourth quarter to exceed market expectations

(Figures in the brackets refer to the same period the previous year) During the fourth quarter of 2025, BioGaia’s sales were positively affected by quarterly variations for individual orders of approximately SEK 35 million. For the fourth quarter, sales are preliminarily estimated at SEK 441 million (365), an increase of 21% (excluding foreign exchange effects, […]